Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2002

01-08-2002 | Originales

Tratamiento radioterápico exclusivo en el carcinoma del pabellón auricular. Análisis de una serie de 104 casos

Authors: Germán Juan Rijo, Ana Alonso García, Ángeles de la Rua Calderón, Paz Pérez Payo, Mercedes Canteli Castahon, Pedro Prada Gómez, Ramón Alonso Pantiga, Asunción Querejeta Recalde, Luis Olay Gayoso, Reinerio Rodríguez

Published in: Clinical and Translational Oncology | Issue 6/2002

Login to get access
Metadata
Title
Tratamiento radioterápico exclusivo en el carcinoma del pabellón auricular. Análisis de una serie de 104 casos
Authors
Germán Juan Rijo
Ana Alonso García
Ángeles de la Rua Calderón
Paz Pérez Payo
Mercedes Canteli Castahon
Pedro Prada Gómez
Ramón Alonso Pantiga
Asunción Querejeta Recalde
Luis Olay Gayoso
Reinerio Rodríguez
Publication date
01-08-2002
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2002
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02832106

Other articles of this Issue 6/2002

Clinical and Translational Oncology 6/2002 Go to the issue

Notas Clínicas

Ameloblastoma de senos paranasales

Original Breve

Quality assurance in interstitial iridium-192 implants for breast cancer

Originales

The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinoma

Revisiones

Envolving treatment of fever and neutropenia in cancer patients

Originales

Malnutrition, maintenance dose intensity and event-free survival in children with acute lymphoblastic leukemia

Editorial

Gastric cancer: multidisciplinary treatment. Changes and challenges
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits